MindWalk Holdings HYFT
NASDAQ HYFT
$1.34 +0.01 (+0.76%)
As of: Sep 4, 2026 · 3:17 PM EDT

MindWalk Holdings (HYFT) Gross Margin Growth (3y) (2023 - 2026)

Analysis

MindWalk Holdings (HYFT) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -168.00
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -65.00
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 14,836.00
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 589.00
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 53.00
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 569.00
10 MindWalk Holdings 62.15 Mn 53.87 Mn 1.82 Mn 119.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 119.00
Jan 31, 2026 194.00
Oct 31, 2025 1,094.00
Jul 31, 2025 -514.00
Apr 30, 2025 59.00
Jan 31, 2025 -942.00
Oct 31, 2024 -755.00
Jul 31, 2024 -1,377.00
Apr 30, 2024 544.00
Jan 31, 2024 -2,748.00
Oct 31, 2023 -1,062.00